
Radiotherapy is the standard of care for breast cancer. However, surviving radioresistant cells can repopulate following treatment and provoke relapse. A better understanding of the molecular mechanisms of radiation resistance may help improve the treatment of radioresistant tumours. It demonstrated a remarkable commonality with radiation and endocrine therapy resistance expression profiles, suggesting crosstalk between both acquired resistance pathways, as indicated by reduced sensitivity to tamoxifen cytotoxicity of FIR20 cells. It was identified a gene‐regulatory network that promotes stemness and inflammatory signalling in FIR20 cells using predictive analyses and functional enrichment.
Like
Save
Share